Thomas Guiel
Director de Operaciones en OXFORD BIODYNAMICS PLC .
Fortuna: 62 195 $ al 31/05/2024
Perfil
Thomas G.
Guiel is currently the Chief Operating Officer at Oxford BioDynamics Plc.
Previously, he held positions as Principal at Invitrogen Corp., Vice President-Operations at OpGen, Inc., and Chief Operating Officer & Executive Vice President at OncoPlex Diagnostics, Inc. from 2013 to 2018.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
OXFORD BIODYNAMICS PLC
0.20% | 03/04/2024 | 623 888 ( 0.20% ) | 62 195 $ | 31/05/2024 |
Cargos activos de Thomas Guiel
Empresas | Cargo | Inicio |
---|---|---|
OXFORD BIODYNAMICS PLC | Director de Operaciones | - |
Antiguos cargos conocidos de Thomas Guiel.
Empresas | Cargo | Fin |
---|---|---|
OncoPlex Diagnostics, Inc.
OncoPlex Diagnostics, Inc. Medical/Nursing ServicesHealth Services OncoPlex Diagnostics, Inc. operates a cancer diagnostics laboratory. It provides information that helps physicians choose targeted therapies and avoid therapies. The company is headquartered in Rockville, MD. | Director de Operaciones | 01/01/2018 |
OPGEN, INC. | Director de Operaciones | - |
Invitrogen Corp.
Invitrogen Corp. Electronic Equipment/InstrumentsElectronic Technology Invitrogen develops, manufactures and markets research tools in kit form and provides other research products and services to corporate, academic and government entities. These research kits simplify and improve gene cloning, gene expression and gene analysis techniques. | Corporate Officer/Principal | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
OPGEN, INC. | Commercial Services |
OXFORD BIODYNAMICS PLC | Health Technology |
Empresas privadas | 2 |
---|---|
Invitrogen Corp.
Invitrogen Corp. Electronic Equipment/InstrumentsElectronic Technology Invitrogen develops, manufactures and markets research tools in kit form and provides other research products and services to corporate, academic and government entities. These research kits simplify and improve gene cloning, gene expression and gene analysis techniques. | Electronic Technology |
OncoPlex Diagnostics, Inc.
OncoPlex Diagnostics, Inc. Medical/Nursing ServicesHealth Services OncoPlex Diagnostics, Inc. operates a cancer diagnostics laboratory. It provides information that helps physicians choose targeted therapies and avoid therapies. The company is headquartered in Rockville, MD. | Health Services |
- Bolsa de valores
- Insiders
- Thomas Guiel